...
首页> 外文期刊>Journal of Translational Medicine >The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis
【24h】

The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis

机译:炎症性肠病发病机制中髓样细胞(TREM)上表达的触发受体

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The Triggering Receptors Expressed on Myeloid cells (TREM) are a family of cell-surface molecules that control inflammation, bone homeostasis, neurological development and blood coagulation. TREM-1 and TREM-2, the best-characterized receptors so far, play divergent roles in several infectious diseases. In the intestine, TREM-1 is highly expressed by macrophages, contributing to inflammatory bowel disease (IBD) pathogenesis. Contrary to current understanding, TREM-2 also promotes inflammation in IBD by fueling dendritic cell functions. This review will focus specifically on recent insights into the role of TREM proteins in IBD development, and discuss opportunities for novel treatment approaches.
机译:髓样细胞(TREM)上表达的触发受体是控制炎症,骨稳态,神经系统发育和血液凝固的细胞表面分子家族。到目前为止,TREM-1和TREM-2是特征最丰富的受体,它们在几种传染病中起着不同的作用。在肠中,TREM-1在巨噬细胞中高度表达,有助于炎症性肠病(IBD)发病机理。与目前的理解相反,TREM-2还通过促进树突状细胞功能促进IBD炎症。这篇综述将特别关注TREM蛋白在IBD发育中的作用的最新见解,并讨论新型治疗方法的机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号